- Total revenues: $96.1M (+4.1%): product sales: $90M (+2.9%), royalties/other: $6.1M (+24.5%).
- Product sales: Sports Medicine: $63.8M (+7.0%), ENT: $24.3M (-5.1%), Other: $1.8M (-18.2%).
- Operating income: $9.2M (-31.9%).
- Net Income: $6.2M (-44.6%), EPS: $0.10 (-66.7%).
- Cash and equivalents at quarter end: $191M.
- CF Ops: -$20.6M compared to +$19.5M yoy.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs